Erratum: Department of Error (The Lancet (2016) 388(10042) (376–389) (S0140673616305906) (10.1016/S0140-6736(16)30590-6));The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies

The Lancet

Volumn 388, Issue 10042, 2016, Pages 376-389

  Charlson, Fiona J ^a,b,c   Baxter, Amanda J ^a,b,c   Cheng, Hui G ^d   Shidhaye, Rahul ^e,f   Whiteford, Harvey A ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Centre for Mental Health Research   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHINA; COMMUNITY; CONDUCT DISORDER; DEMENTIA; DEPRESSION; DISEASE DURATION; DRUG DEPENDENCE; EPILEPSY; HUMAN; INCIDENCE; INDIA; INTELLECTUAL IMPAIRMENT; MATHEMATICAL MODEL; MENTAL DISEASE; MENTAL HEALTH; MORTALITY; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SYSTEMATIC REVIEW; DEVELOPING COUNTRY; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS;

CHINA; DEVELOPING COUNTRIES; HUMANS; INCIDENCE; INDIA; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84975498446     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31863-3     Document Type: Erratum

References (36)

1. 1 Demyttenaere, K, Bruffaerts, R, Posada-Villa, J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291 (2004), 2581–2590.
2. 2 Phillips, MR, Zhang, J, Shi, Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 373 (2009), 2041–2053.
3. 3 Murthy, RS, Mental health initiatives in India (1947–2010). Natl Med J India 24 (2011), 98–107.
4. 4 Murray, CJL, Lopez, AD, The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, 1996, Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Cambridge, MA.
5. 5 WHO. mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings: Mental Health Gap Action Programme (mhGAP). mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings: Mental Health Gap Action Programme (mhGAP), 2010, World Health Organization, Geneva.
6. 6 GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
7. 7 Whiteford, HA, Degenhardt, L, Rehm, J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382 (2013), 1575–1586.
8. 8 Haagsma, JA, de Noordhout, CM, Polinder, S, et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr, 13, 2015, 1.
9. 9 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
10. 10 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
11. 11 Zhou, M, Wang, H, Zhu, J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387 (2016), 251–272.
12. 12 Salomon, JA, Wang, H, Freeman, MK, et al. Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 380 (2013), 2144–2162.
13. 13 Bruckner, TA, Scheffler, RM, Shen, G, et al. The mental health workforce gap in low-and middle-income countries: a needs-based approach. Bull World Health Organ 89 (2011), 184–194.
14. 14 Patel, V, Thornicroft, G, Packages of care for mental, neurological, and substance use disorders in low-and middle-income countries: PLoS Medicine Series. PLoS Med, 6, 2009, e1000160.
15. 15 Charlson, FJ, Diminic, S, Lund, C, Degenhardt, L, Whiteford, HA, Mental and substance use disorders in sub-Saharan Africa: predictions of epidemiological changes and mental health workforce requirements for the next 40 years. PLoS One, 9, 2014, e110208.
16. 16 Baxter, AJ, Scott, KM, Ferrari, AJ, Norman, RE, Vos, T, Whiteford, HA, Challenging the myth of an ‘epidemic’ of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety 31 (2014), 506–516.
17. 17 Chen, H, Phillips, M, Cheng, H, et al. Mental Health Law of the People's Republic of China (English translation with annotations): translated and annotated version of China's new Mental Health Law. Shanghai Arch Psychiatry 24 (2012), 305–321.
18. 18 Armstrong, G, Kermode, M, Raja, S, Suja, S, Chandra, P, Jorm, AF, A mental health training program for community health workers in India: impact on knowledge and attitudes. Int J Ment Health Syst, 5, 2011, 17.
19. 19 Lozano, R, Naghavi, M, Foreman, K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
20. 20 National Health and Family Planning Commission of the People's Republic of China. Regulation of prevention and intervention of epilepsy in rural areas, 2007, National Health and Family Planning Commission of the People's Republic of China, Beijing.
21. 21 Li, N, Du, W, Chen, G, Song, X, Zheng, X, Mental health service use among Chinese adults with mental disabilities: a national survey. Psychiatr Serv 64 (2013), 638–644.
22. 22 Tian, D, Qu, Z, Wang, X, et al. The role of basic health insurance on depression: an epidemiological cohort study of a randomized community sample in northwest China. BMC Psychiatry, 12, 2012, 151.
23. 23 Zhou, Y, Rosenheck, RA, He, H, Health insurance in China: variation in co-payments and psychiatric hospital utilization. J Ment Health Policy Econ 17 (2014), 25–32.
24. 24 Chen, W, Hong, Y, Zou, X, McLaughlin, MM, Xia, Y, Ling, L, Effectiveness of prize-based contingency management in a methadone maintenance program in China. Drug Alcohol Depend 133 (2013), 270–274.
25. 25 Patel, V, Weiss, HA, Chowdhary, N, et al. Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomised controlled trial. Lancet 376 (2010), 2086–2095.
26. 26 Chatterjee, S, Naik, S, John, S, et al. Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial. Lancet 383 (2014), 1385–1394.
27. 27 Thara, R, John, S, Rao, K, Telepsychiatry in Chennai, India: the SCARF experience. Behav Sci Law 26 (2008), 315–322.
28. 28 Lund, C, Tomlinson, M, De Silva, M, et al. PRIME: a programme to reduce the treatment gap for mental disorders in five low- and middle-income countries. PLoS Med, 9, 2012, e1001359.
29. 29 Shidhaye, R, Patel, V, Improving access to mental healthcare in India: opportunities and innovations. India Infrastructure Report 2013–2014: The Road to Universal Health Coverage, 2014, Orient Blackswan, New Delhi.
30. 30 Xin, Z, Niu, J, Chi, L, Birth cohort changes in Chinese adolescents' mental health. Int J Psychol 47 (2012), 287–295.
31. 31 Cameron, L, Erkal, N, Gangadharan, L, Meng, X, Little emperors: behavioral impacts of China's One-Child Policy. Science 339 (2013), 953–957.
32. 32 Zhang, Z-X, Chen, X, Liu, X-H, et al. A caregiver survey in Beijing, Xi'an, Shanghai and Chengdu: health services status for the elderly with dementia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26 (2004), 116–121 (in Chinese).
33. 33 Wu, Y-T, Lee, H-Y, Norton, S, et al. Prevalence studies of dementia in mainland china, Hong Kong and taiwan: a systematic review and meta-analysis. PLoS One, 8, 2013, e66252.
34. 34 Cheng, HG, Deng, F, Xiong, W, Phillips, MR, Prevalence of alcohol use disorders in mainland China: a systematic review. Addiction 110 (2015), 761–774.
35. 35 Charlson, FJ, Baxter, AJ, Degenhardt, L, Whiteford, H, Vos, T, Excess mortality from mental, neurological, and substance use disorders in the Global Burden of Disease Study 2010. Patel, V, Chisholm, D, Dua, T, Laxminarayan, R, Elena Medina-Mora, M, (eds.) Disease Control Priorities in Developing Countries, 3rd edn., 2015, International Bank for Reconstruction and Development/The World Bank, Washington DC.
36. 36 Baxter, AJ, Patton, G, Degenhardt, L, Scott, KM, Whiteford, HA, Global epidemiology of mental disorders: what are we missing?. PLoS One, 8, 2013, e65514.